Article: PharmaCentra Partners with Rollins School of Public Health and the School of Medicine at Emory University to Increase Glaucoma Treatment Compliance.

Article: Computer-enhanced treatment compliance: new devices ...
Behavioral Health Management;  March 1, 2004 ;     700+ words ... ... psychiatric medications in the United States, however, and therefore are not widely applicable in monitoring treatment compliance in patients with schizophrenia and bipolar disorder. More appropriate are the MEMS and Med-eMonitor. The ...

Article: Cultural sensitivity boosts treatment ...
Skin & Allergy News;  January 1, 2008 ;     700+ words ... ... understand cultural background leads to miscommunication in the doctor-patient relationship and can result in poor treatment compliance. Approximately 42 million people in the United States are ethnically identified as Hispanic. The term Hispanic ...

Article: Multiple factors affect psoriasis treatment ...
Biotech Week;  May 12, 2004 ;     700+ words ... ... Archives of Dermatology. Patients completed a brief medical and social history and answered questions about their treatment compliance and their quality of life as related to their psoriasis at the beginning of the study. Patients were re-evaluated ...

Article: CDC PUSHES ANTHRAX TREATMENT COMPLIANCE
United Press International;  November 15, 2001 ;     626 words ...United Press International 11-15-2001 CDC pushes anthrax treatment compliance WASHINGTON, Nov 15, 2001 (United Press International via COMTEX) -- There have been no new anthrax cases anywhere in the nation ...

Article: Study looks at treatment compliance among ...
TB & Outbreaks Week;  January 21, 2003 ;     692 words ... ... IL 60062-2348, USA. The information in this article comes under the major subject areas of Tuberculosis, Treatment Compliance, Healthcare Workers. This article was prepared by TB & Outbreaks Week editors from staff and other reports ...

Article: Monthly Boniva raises treatment compliance.(Roche ...
Pharma Marketletter;  September 25, 2006 ;     700+ words ... ... sodium), the agent it is co-developing with the UK's GlaxoSmithKline, were 25% more likely to maintain treatment compliance than those taking weekly bisphosphonates. Lead investigator Stuart Silverman, a clinical professor of medicine ...

Article: Low co-pay generics improve treatment compliance ...
Pharma Marketletter;  December 4, 2006 ;     700+ words ... ... maintain their drug treatment program if co-payments are low. The data were gathered from research into the treatment compliance for cholesterol-lowering statins and antihypertensitive drugs. Prime concludes that making low-cost drugs ...